KELI From Inkwell, this is the Independent News Drop. It's Saturday, May thirtieth. The time is six a.m. central. I'm Keli, with Hast.
HAST Morning. We're leading with Venezuela this morning — a moment that got buried under a joke.
KELI From our Ground News desk: back in January, the U.S. captured Nicolás Maduro and installed Delcy Rodríguez as Venezuela's new president. That happened. Last month, Trump was asked about his political future and said on the record: "I'm polling higher than anybody has ever polled in Venezuela. So after I'm finished with this, I can go to Venezuela. I'm going to run for president." Most newsrooms ran the surface read — the joke about learning Spanish. But here's the structural story: he's claiming sky-high approval ratings in a country under American occupation, a country where the U.S. just chose the government he'd theoretically be running against. The gap between what he said and what got reported matters. Watch the coming weeks for how Venezuela's new government responds to that statement — whether it becomes a diplomatic complication or whether it fades because the occupation itself hasn't been the lead story stateside.
HAST Shifting to medicine now. Pancreatic cancer researchers have a new opening.
KELI STAT News is reporting on results from the American Society of Clinical Oncology conference this week. A drug from Revolution Medicines appears to have found a way to target what researchers call a "greasy ball" — a protein called KRAS that's been nearly impossible to drug. The early trial data shows the compound can extend survival in some pancreatic cancer patients. This is continuing coverage, but the numbers being presented are the kind that can shift treatment guidelines. We'll have the breakdown on what this means for patients in the next few hours.
HAST On a different front, Lebanon. Israeli forces have now seized Beaufort Castle — that's in southern Lebanon, a strategic medieval position overlooking the Zahrani river.
KELI The BBC reports the Israeli military is telling civilians south of that river to evacuate. The castle sits on high ground, historically a chokepoint. This is a new escalation in the ground offensive there — we've been tracking the border tensions for weeks, but the move into fortified positions suggests a longer presence than the military has signaled publicly. That one's worth watching for whether it becomes a statement about expanded territorial control or a tactical maneuver.
HAST Different scale, but Brazil's police violence is getting harder to ignore.
KELI Al Jazeera has a documentary called "Rio's Forever War" looking back at 2025 — specifically a police raid that killed 120 people and exposed a pattern of mishandled evidence and impunity in Rio's favelas. The raid itself was brutal, but the follow-up investigation found the authorities weren't preserving crime scenes, weren't documenting ballistics properly. It's a story about institutional failure, not just one operation. Brazil's interior ministry has been under pressure to reform, but the documentary suggests the structural problems run deeper.
HAST Last one — lung cancer research that happened in China but matters to Western doctors.
KELI At the same ASCO conference, a drug called ivonescimab, developed by Akeso and Summit, is showing survival benefits in squamous cell lung cancer. The wrinkle: doctors want to see the data replicated in a more diverse patient population. It's a practice-changing result if it holds, but the medical community is being appropriately cautious about applying findings from one trial too broadly. That's the careful science happening behind the headlines.
HAST Before we close, a date marker.
KELI On this day in 2008, the Convention on Cluster Munitions was adopted — an international treaty banning a weapon that kills indiscriminately after conflict ends.
KELI That's the Independent News Drop. We'll be back this evening. From Inkwell.